Fuse Oncology provides business and clinical intelligence solution for radiation oncology.
Fuse Oncology has raised $8.9M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Fuse Oncology's investors include Cone Health, Northeast Georgia Health System, First Launch Capital Fund.
Fuse Oncology is headquartered in Greensboro, United States.
Fuse Oncology provides business and clinical intelligence solution for radiation oncology.
Fuse Oncology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fuse Oncology — Funding & Investors." VCBacked, April 21, 2023, https://www.vcbacked.co/company/fuse-oncology. Accessed October 29, 2026.
VCBacked. (2023). Fuse Oncology — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/fuse-oncology
{{cite web |title=Fuse Oncology — Funding & Investors |url=https://www.vcbacked.co/company/fuse-oncology |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated